Search Results

MYK-461 5mg  | 99.73%

APEXBIO TECHNOLOGY LLC

inhibits adenosine triphosphatase activity Membrane Transporter/Ion Channel|ATPase

More Information Supplier Page

×

MYK-461

MYK-461 10mM (in 1mL DMSO)  | 99.73%

APEXBIO TECHNOLOGY LLC

inhibits adenosine triphosphatase activity Membrane Transporter/Ion Channel|ATPase

More Information Supplier Page

×

MYK-461

ML 239 25mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of the breast cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML 239

THZ2 100mg  | 98.08%

APEXBIO TECHNOLOGY LLC

CDK7 inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

THZ2

GX-674 5mg  | 98%

APEXBIO TECHNOLOGY LLC

Nav1.7 antagonist Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

GX-674

GX-674 25mg  | 98%

APEXBIO TECHNOLOGY LLC

Nav1.7 antagonist Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

GX-674

ML 239 5mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of the breast cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML 239

ML 239 10mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of the breast cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML 239

THZ2 50mg  | 98.08%

APEXBIO TECHNOLOGY LLC

CDK7 inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

THZ2

THZ2 10mg  | 98.08%

APEXBIO TECHNOLOGY LLC

CDK7 inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

THZ2